Tumour-Infiltrating Clonal Haematopoiesis Increases the Risk of Recurrence or Death Among Patients with NSCLC and the Risk of Death From Any Cause Among Patients with Solid Tumours By Ogkologos - May 7, 2025 606 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the analysis of TRACERx and MSK-IMPACT studies Source RELATED ARTICLESMORE FROM AUTHOR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma EMA Recommends Extension of Therapeutic Indications for Retifanlimab MOST POPULAR Getting cancer services back on track during the COVID-19 pandemic June 22, 2020 6 Habits That Can Help You Feel More in Control of... November 30, 2022 Intensive care nurse describes his experience of female-centred care after breast... February 7, 2023 ΚΑΡΚΙΝΟΣ ΘΥΡΕΟΕΙΔΟΥΣ February 10, 2019 Load more HOT NEWS How I Learned to Cope With Survivor’s Guilt After Cancer New on NCI’s Websites for August 2024 Perioperative Durvalumab Plus Neoadjuvant Chemotherapy Improves EFS and OS in Cisplatin-Eligible... Partnership in a pandemic: how Credit Suisse delivered an incredible Charity...
